Molecular Characteristics and Exotoxins of Methicillin-Resistant Staphylococcus aureus
暂无分享,去创建一个
[1] Rendong Fang,et al. Update on molecular diversity and multipathogenicity of staphylococcal superantigen toxins , 2021, Animal Diseases.
[2] اسماعیل اصلی,et al. 31 , 2012, Tao te Ching.
[3] D. van Duin,et al. Multidrug-Resistant Bacteria in the Community: An Update. , 2020, Infectious disease clinics of North America.
[4] N. Hussein,et al. Characterization of different virulent factors in methicillin-resistant Staphylococcus aureus isolates recovered from Iraqis and Syrian refugees in Duhok city, Iraq , 2020, PloS one.
[5] K. Shettigar,et al. Virulence factors and clonal diversity of Staphylococcus aureus in colonization and wound infection with emphasis on diabetic foot infection , 2020, European Journal of Clinical Microbiology & Infectious Diseases.
[6] J. Capelo,et al. Genetic Characterization of Methicillin-Resistant Staphylococcus aureus Isolates from Human Bloodstream Infections: Detection of MLSB Resistance , 2020, Antibiotics.
[7] H. Njom,et al. Antibiotic Resistance and Virulence Gene Characteristics of Methicillin-Resistant Staphylococcus aureus (MRSA) Isolated from Healthy Edible Marine Fish , 2020, International journal of microbiology.
[8] J. Décout,et al. Synthesis and Evaluation of 2‐Aminothiophene Derivatives as Staphylococcus aureus Efflux Pump Inhibitors , 2020, ChemMedChem.
[9] Qing Zhan,et al. Subinhibitory Concentrations of Fusidic Acid May Reduce the Virulence of S. aureus by Down-Regulating sarA and saeRS to Reduce Biofilm Formation and α-Toxin Expression , 2020, Frontiers in Microbiology.
[10] Han Yang,et al. Prevalence and molecular characterization of methicillin-resistant Staphylococcus aureus with mupirocin, fusidic acid and/or retapamulin resistance , 2020, BMC Microbiology.
[11] A. van Belkum,et al. Mupirocin Resistance in Staphylococcus aureus: A Systematic Review and Meta-Analysis. , 2020, Journal of global antimicrobial resistance.
[12] H. Ismail,et al. Unconventional SCCmec types and low prevalence of the Panton-Valentine Leukocidin exotoxin in South African blood culture Staphylococcus aureus surveillance isolates, 2013-2016 , 2019, PloS one.
[13] S. Monecke,et al. Characterisation of a novel SCCmec VI element harbouring fusC in an emerging Staphylococcus aureus strain from the Arabian Gulf region , 2019, PloS one.
[14] S. Abbasian,et al. The prevalence of exotoxins, adhesion, and biofilm-related genes in Staphylococcus aureus isolates from the main burn center of Tehran, Iran , 2019, Iranian journal of basic medical sciences.
[15] T. Foster. The MSCRAMM Family of Cell-Wall-Anchored Surface Proteins of Gram-Positive Cocci. , 2019, Trends in microbiology.
[16] S. Mobashery,et al. Constructing and deconstructing the bacterial cell wall , 2019, Protein science : a publication of the Protein Society.
[17] M. Elasri,et al. Role of the msaABCR Operon in Cell Wall Biosynthesis, Autolysis, Integrity, and Antibiotic Resistance in Staphylococcus aureus , 2019, Antimicrobial Agents and Chemotherapy.
[18] H. Smart,et al. 25-Hydroxyvitamin D Deficiency: Impacting Deep-Wound Infection and Poor Healing Outcomes in Patients With Diabetes. , 2019, Advances in skin & wound care.
[19] A. Bazargani,et al. Characterization of SCCmec, spa types and Multi Drug Resistant of methicillin-resistant Staphylococcus aureus isolates among inpatients and outpatients in a referral hospital in Shiraz, Iran , 2019, BMC Research Notes.
[20] Yifan Rao,et al. Virulence Determinants Are Required for Brain Abscess Formation Through Staphylococcus aureus Infection and Are Potential Targets of Antivirulence Factor Therapy , 2019, Front. Microbiol..
[21] M. Vestergaard,et al. Antibiotic Resistance and the MRSA Problem , 2019, Microbiology spectrum.
[22] V. Torres,et al. Staphylococcus aureus Secreted Toxins and Extracellular Enzymes , 2019, Microbiology spectrum.
[23] M. Jit,et al. Determinants of MRSA prevalence in the Asia Pacific Region : a systematic review and meta-analysis , 2018 .
[24] E. Farrokhi,et al. Prevalence and distribution of adhesins and the expression of fibronectin-binding protein (FnbA and FnbB) among Staphylococcus aureus isolates from Shahrekord Hospitals , 2019, BMC Research Notes.
[25] H. Motamedi,et al. Identification of Hemolysine Genes and their Association with Antimicrobial Resistance Pattern among Clinical Isolates of Staphylococcus aureus in West of Iran , 2018, Advanced biomedical research.
[26] N. Papanas,et al. To Smoke or Not To Smoke: Cigarettes Have a Negative Effect on Wound Healing of Diabetic Foot Ulcers , 2018, The international journal of lower extremity wounds.
[27] V. Perreten,et al. The integrase of the Macrococcus caseolyticus resistance island mecD (McRImecD) inserts DNA site‐specifically into Staphylococcus and Bacillus chromosomes , 2018, Molecular microbiology.
[28] Sahreena S. Lakhundi,et al. Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology , 2018, Clinical Microbiology Reviews.
[29] Livy. 62 , 2018, Tao te Ching.
[30] T. Johannesen,et al. Novel SCCmec type XIII (9A) identified in an ST152 methicillin-resistant Staphylococcus aureus. , 2018, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[31] M. Simões,et al. Staphylococcus aureus Toxins and Their Molecular Activity in Infectious Diseases , 2018, Toxins.
[32] Y. Dufrêne,et al. Staphylococcus aureus clumping factor A is a force-sensitive molecular switch that activates bacterial adhesion , 2018, Proceedings of the National Academy of Sciences.
[33] E. Martin,et al. Clinical and Genetic Risk Factors for Biofilm-Forming Staphylococcus aureus , 2018, Antimicrobial Agents and Chemotherapy.
[34] F. Laurent,et al. Staphylococcal Adhesion and Host Cell Invasion: Fibronectin-Binding and Other Mechanisms , 2017, Front. Microbiol..
[35] J. Bubeck Wardenburg,et al. Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity. , 2017, Seminars in cell & developmental biology.
[36] R. Sassi,et al. PDF-ECG in clinical practice: A model for long-term preservation of digital 12-lead ECG data. , 2017, Journal of electrocardiology.
[37] C. Rodrigues,et al. Staphylococcus aureus δ-toxin in aqueous solution: Behavior in monomeric and multimeric states. , 2017, Biophysical chemistry.
[38] Jinwei Huang,et al. Dissemination of macrolides, fusidic acid and mupirocin resistance among Staphylococcus aureus clinical isolates , 2017, Oncotarget.
[39] S. Walker,et al. Peptidoglycan Cross-Linking Preferences of Staphylococcus aureus Penicillin-Binding Proteins Have Implications for Treating MRSA Infections. , 2017, Journal of the American Chemical Society.
[40] J. Haldar,et al. A review on cell wall synthesis inhibitors with an emphasis on glycopeptide antibiotics. , 2017, MedChemComm.
[41] P. Schlievert,et al. Staphylococcal β-Toxin Modulates Human Aortic Endothelial Cell and Platelet Function through Sphingomyelinase and Biofilm Ligase Activities , 2017, mBio.
[42] A. Dessen,et al. New strategies for targeting and treatment of multi-drug resistant Staphylococcus aureus. , 2017, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[43] E. Coccia,et al. Worldwide Epidemiology and Antibiotic Resistance of Staphylococcus aureus. , 2016, Current topics in microbiology and immunology.
[44] R. Platt,et al. Chlorhexidine and Mupirocin Susceptibility of Methicillin-Resistant Staphylococcus aureus Isolates in the REDUCE-MRSA Trial , 2016, Journal of Clinical Microbiology.
[45] G. Nath,et al. Association of Panton Valentine Leukocidin (PVL) genes with methicillin resistant Staphylococcus aureus (MRSA) in Western Nepal: a matter of concern for community infections (a hospital based prospective study) , 2016, BMC Infectious Diseases.
[46] Soojin Jang. Multidrug efflux pumps in Staphylococcus aureus and their clinical implications , 2016, Journal of Microbiology.
[47] A. Horswill,et al. Staphylococcus aureus Aggregation and Coagulation Mechanisms, and Their Function in Host-Pathogen Interactions. , 2016, Advances in applied microbiology.
[48] Emilia A. Bonar,et al. Proteomics in studies of Staphylococcus aureus virulence. , 2015, Acta biochimica Polonica.
[49] P. Fey,et al. Staphylococcus aureus Biofilms Induce Macrophage Dysfunction Through Leukocidin AB and Alpha-Toxin , 2015, mBio.
[50] S. Peacock,et al. Mechanisms of Methicillin Resistance in Staphylococcus aureus. , 2015, Annual review of biochemistry.
[51] Vance G. Fowler,et al. Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management , 2015, Clinical Microbiology Reviews.
[52] James C. Whisstock,et al. Perforin and granzymes: function, dysfunction and human pathology , 2015, Nature Reviews Immunology.
[53] V. Perreten,et al. First Staphylococcal Cassette Chromosome mec Containing a mecB-Carrying Gene Complex Independent of Transposon Tn6045 in a Macrococcus caseolyticus Isolate from a Canine Infection , 2015, Antimicrobial Agents and Chemotherapy.
[54] X. Rao,et al. Panton-Valentine Leukocidin (PVL)-Positive Health Care-Associated Methicillin-Resistant Staphylococcus aureus Isolates Are Associated with Skin and Soft Tissue Infections and Colonized Mainly by Infective PVL-Encoding Bacteriophages , 2014, Journal of Clinical Microbiology.
[55] Y. Tor,et al. Antibiotics and Bacterial Resistance in the 21st Century , 2014, Perspectives in medicinal chemistry.
[56] M. Elasri,et al. The msaABCR Operon Regulates Resistance in Vancomycin-Intermediate Staphylococcus aureus Strains , 2014, Antimicrobial Agents and Chemotherapy.
[57] A. Petersen,et al. β-Lactam Resistance in Methicillin-Resistant Staphylococcus aureus USA300 Is Increased by Inactivation of the ClpXP Protease , 2014, Antimicrobial Agents and Chemotherapy.
[58] Anthony Z. Matolek,et al. Separately or Combined, LukG/LukH Is Functionally Unique Compared to Other Staphylococcal Bicomponent Leukotoxins , 2014, PloS one.
[59] V. Torres,et al. Cell targeting by the Staphylococcus aureus pore-forming toxins: it's not just about lipids. , 2014, Trends in microbiology.
[60] K. Christiansen,et al. Increased EMRSA-15 health-care worker colonization demonstrated in retrospective review of EMRSA hospital outbreaks , 2014, Antimicrobial Resistance and Infection Control.
[61] Timothy J. Foster,et al. Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus , 2013, Nature Reviews Microbiology.
[62] M. de Martino,et al. Evidence of transmission of a Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus clone: a family affair. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[63] M. Otto. Community-associated MRSA: what makes them special? , 2013, International journal of medical microbiology : IJMM.
[64] J. Lindsay. Hospital-associated MRSA and antibiotic resistance-what have we learned from genomics? , 2013, International journal of medical microbiology : IJMM.
[65] P. Schlievert,et al. Staphylococcal and Streptococcal Superantigen Exotoxins , 2013, Clinical Microbiology Reviews.
[66] P. Krishnan,et al. High Prevalence of Exfoliative Toxins Among Carrier Isolates of Staphylococcus aureus from Healthy Individuals from Various Communities in Chennai, South India , 2013, Indian Journal of Microbiology.
[67] V. Torres,et al. The effects of Staphylococcus aureus leukotoxins on the host: cell lysis and beyond. , 2013, Current opinion in microbiology.
[68] J. Parkhill,et al. A Staphylococcus xylosus Isolate with a New mecC Allotype , 2012, Antimicrobial Agents and Chemotherapy.
[69] M. Otto. MRSA virulence and spread , 2012, Cellular microbiology.
[70] D. Cooper,et al. Development of a multicomponent Staphylococcus aureus vaccine designed to counter multiple bacterial virulence factors , 2012, Human vaccines & immunotherapeutics.
[71] G. Nimmo. USA300 abroad: global spread of a virulent strain of community-associated methicillin-resistant Staphylococcus aureus. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[72] B. Limbago,et al. Prevalence of methicillin-resistant staphylococcus aureus as an etiology of community-acquired pneumonia. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[73] C. Gross,et al. From the regulation of peptidoglycan synthesis to bacterial growth and morphology , 2011, Nature Reviews Microbiology.
[74] 김진복,et al. 63 , 1983, Skipr.
[75] V. Fowler,et al. Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance? , 2011, Seminars in Immunopathology.
[76] S. Delgado,et al. Characterization of Staphylococcus aureus strains involved in human and bovine mastitis. , 2011, FEMS immunology and medical microbiology.
[77] T. Xue,et al. Rot and Agr system modulate fibrinogen-binding ability mainly by regulating clfB expression in Staphylococcus aureus NCTC8325 , 2011, Medical Microbiology and Immunology.
[78] A. Kruse,et al. Beta toxin catalyzes formation of nucleoprotein matrix in staphylococcal biofilms , 2010, Proceedings of the National Academy of Sciences.
[79] R. Daum,et al. Community-Associated Methicillin-Resistant Staphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic , 2010, Clinical Microbiology Reviews.
[80] J. Lindsay. Genomic variation and evolution of Staphylococcus aureus. , 2010, International journal of medical microbiology : IJMM.
[81] G. Pfyffer,et al. Emergence of SCCmec Type IV and SCCmec Type V Methicillin-Resistant Staphylococcus aureus Containing the Panton-Valentine Leukocidin Genes in a Large Academic Teaching Hospital in Central Switzerland: External Invaders or Persisting Circulators? , 2009, Journal of Clinical Microbiology.
[82] B. Saha,et al. IL-2 Regulates SEB Induced Toxic Shock Syndrome in BALB/c Mice , 2009, PloS one.
[83] G. Núñez,et al. A Critical Role for Hemolysins and Bacterial Lipoproteins in Staphylococcus aureus-Induced Activation of the Nlrp3 Inflammasome1 , 2009, The Journal of Immunology.
[84] Henry F. Chambers,et al. Waves of resistance: Staphylococcus aureus in the antibiotic era , 2009, Nature Reviews Microbiology.
[85] E. Eichenwald,et al. Seven-Year Experience With a Surveillance Program to Reduce Methicillin-Resistant Staphylococcus aureus Colonization in a Neonatal Intensive Care Unit , 2009, Pediatrics.
[86] Jia Cao,et al. A broad-spectrum inhibitory peptide against staphylococcal enterotoxin superantigen SEA, SEB and SEC. , 2008, Immunology letters.
[87] B. Diep,et al. The role of virulence determinants in community-associated MRSA pathogenesis. , 2008, Trends in microbiology.
[88] T. Foster,et al. Identification of the Staphylococcus aureus MSCRAMM clumping factor B (ClfB) binding site in the αC-domain of human fibrinogen , 2008, Microbiology.
[89] A. Kumar. Invasive Methicillin-Resistant Staphylococcus aureus Infections in the United States , 2008 .
[90] Roberta B Carey,et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. , 2007, JAMA.
[91] D. Coleman,et al. The Emergence and Importation of Diverse Genotypes of Methicillin-Resistant Staphylococcus aureus (MRSA) Harboring the Panton-Valentine Leukocidin Gene (pvl) Reveal that pvl Is a Poor Marker for Community-Acquired MRSA Strains in Ireland , 2007, Journal of Clinical Microbiology.
[92] Weizhong Yang,et al. Streptococcal Toxic Shock Syndrome Caused by Streptococcus suis Serotype 2 , 2006, PLoS Medicine.
[93] J. Kluytmans,et al. The emergence of infections with community-associated methicillin resistant Staphylococcus aureus. , 2006, The Journal of infection.
[94] Christof R Hauck,et al. Sticky connections: extracellular matrix protein recognition and integrin-mediated cellular invasion by Staphylococcus aureus. , 2006, Current opinion in microbiology.
[95] A. Boulton,et al. The global burden of diabetic foot disease , 2005, The Lancet.
[96] G. Duckworth,et al. Surveillance and epidemiology of MRSA bacteraemia in the UK. , 2005, The Journal of antimicrobial chemotherapy.
[97] D. Landman,et al. Community-associated Methicillin-resistant Staphylococcus aureus in Hospital Nursery and Maternity Units , 2005, Emerging infectious diseases.
[98] S. Loncarevic,et al. Diversity of Staphylococcus aureus enterotoxin types within single samples of raw milk and raw milk products , 2005, Journal of applied microbiology.
[99] Judith R. Campbell,et al. Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[100] S. Loncarevic,et al. Modified Multiplex PCR Method for Detection of Pyrogenic Exotoxin Genes in Staphylococcal Isolates , 2004, Journal of Clinical Microbiology.
[101] E. Greenberg,et al. Quorum Sensing in Staphylococcus aureus Biofilms , 2004, Journal of bacteriology.
[102] H. de Lencastre,et al. Bridges from hospitals to the laboratory: genetic portraits of methicillin-resistant Staphylococcus aureus clones. , 2004, FEMS immunology and medical microbiology.
[103] P. Graham,et al. Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[104] T. Proft,et al. Bacterial superantigens , 2003, Clinical and experimental immunology.
[105] D. Sheehan,et al. Relationship between haemolytic and sphingomyelinase activities in a partially purified beta-like toxin from Staphylococcus schleiferi. , 2003, FEMS immunology and medical microbiology.
[106] A. Friedrich,et al. Prevalence of Genes Encoding Pyrogenic Toxin Superantigens and Exfoliative Toxins among Strains of Staphylococcus aureus Isolated from Blood and Nasal Specimens , 2003, Journal of Clinical Microbiology.
[107] G. Lina,et al. Prevalence of agr Specificity Groups among Staphylococcus aureus Strains Colonizing Children and Their Guardians , 2003, Journal of Clinical Microbiology.
[108] Alexander Bürkle,et al. - 3 ( 7 , 2003 .
[109] B. Cookson,et al. A new UK strain of epidemic methicillin-resistant Staphylococcus aureus (EMRSA-17) resistant to multiple antibiotics. , 2002, The Journal of antimicrobial chemotherapy.
[110] S. Ladhani. Recent developments in staphylococcal scalded skin syndrome. , 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[111] J. Kaneko,et al. Phage conversion of Panton-Valentine leukocidin in Staphylococcus aureus: molecular analysis of a PVL-converting phage, phiSLT. , 2001, Gene.
[112] P. François,et al. Clumping factor B (ClfB), a new surface‐located fibrinogen‐binding adhesin of Staphylococcus aureus , 1998, Molecular microbiology.
[113] D Roberts,et al. Staphylococcal food poisoning in the United Kingdom, 1969–90 , 1993, Epidemiology and Infection.
[114] F H Kayser,et al. Growing clinical significance of methcillin-resistant Staphylococcus aureus. , 1968, Lancet.